Revelation Capital Management as of Sept. 30, 2022
Portfolio Holdings for Revelation Capital Management
Revelation Capital Management holds 3 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Singular Genomics Systems In | 83.2 | $3.5M | 1.4M | 2.50 | |
| Akili (AKLI) | 13.1 | $556k | 246k | 2.26 | |
| Neuropace (NPCE) | 3.8 | $161k | 43k | 3.75 |
